Chapter title |
Clinical studies with curcumin.
|
---|---|
Chapter number | 21 |
Book title |
The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease
|
Published in |
Advances in experimental medicine and biology, February 2016
|
DOI | 10.1007/978-0-387-46401-5_21 |
Pubmed ID | |
Book ISBNs |
978-0-387-46400-8, 978-0-387-46401-5
|
Authors |
Chih-Hung Hsu, Ann-Lii Cheng, Hsu CH, Cheng AL, Hsu, Chih-Hung, Cheng, Ann-Lii |
Editors |
Bharat B. Aggarwal Ph.D., Young-Joon Surh Ph.D., Shishir Shishodia Ph.D. |
Abstract |
Curcumin has long been expected to be a therapeutic or preventive agent for several major human diseases because of its antioxidative, anti-inflammatory, and anticancerous effects. In phase I clinical studies, curcumin with doses up to 3600-8000 mg daily for 4 months did not result in discernible toxicities except mild nausea and diarrhea. The pharmacokinetic studies of curcumin indicated in general a low bioavailability of curcumin following oral application. Nevertheless, the pharmacologically active concentration of curcumin could be achieved in colorectal tissue in patients taking curcumin orally and might also be achievable in tissues such as skin and oral mucosa, which are directly exposed to the drugs applied locally or topically. The effect of curcumin was studied in patients with rheumatoid arthritis, inflammatory eye diseases, inflammatory bowel disease, chronic pancreatitis, psoriasis, hyperlipidemia, and cancers. Although the preliminary results did support the efficacy of curcumin in these diseases, the data to date are all preliminary and not conclusive. It is imperative that well-designed clinical trials, supported by better formulations of curcumin or novel routes of administration, be conducted in the near future. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 33% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Science communicators (journalists, bloggers, editors) | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 1% |
India | 1 | <1% |
Greece | 1 | <1% |
Australia | 1 | <1% |
Unknown | 267 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 44 | 16% |
Student > Ph. D. Student | 40 | 15% |
Student > Master | 39 | 14% |
Researcher | 25 | 9% |
Student > Postgraduate | 20 | 7% |
Other | 54 | 20% |
Unknown | 51 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 56 | 21% |
Agricultural and Biological Sciences | 42 | 15% |
Biochemistry, Genetics and Molecular Biology | 25 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 23 | 8% |
Chemistry | 22 | 8% |
Other | 44 | 16% |
Unknown | 61 | 22% |